Bayer Healthcare Pharmaceuticals Inc. to Update Yaz & Yasmin Warning Label
According to press reports, Bayer Healthcare Pharmaceuticals has agreed to change its warning labels on their oral contraceptive drugs Yaz and Yasmin to alert users to the risks of developing blood clots while using Yaz and Yasmin. The newly updated labels will now state that the risk of using these two birth control products is “comparable” to that of other oral contraceptives. However, as alleged in complaints against Bayer by injured patients and the families of loved ones, who have died, Yaz and Yasmin are dangerous drugs, posing a greater risk of blood clots and serious injuries than earlier generations of birth control pills that are available for use in the U.S. and worldwide.
The decision to update the labels came after two studies that were commissioned by Bayer showed that the risk of Yaz and Yasmin was comparable to that of other oral contraceptives on the market, according to press reports.
Click here to learn more about the risks associated with Yaz and Yasmin.
